Month: February 2026

TORONTO, Feb. 17, 2026 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) announced today it will host a fourth quarter conference call and live audio webcast on March 10, 2026 at 8:00 a.m. ET. The Company’s quarterly results will be disseminated via press release, and made available on the Company’s website (www.csisoftware.com) and SEDAR+ (www.sedarplus.ca), after the Toronto Stock Exchange closes on Monday, March 9, 2026. Mark Miller, President, Jamal Baksh, Chief Financial Officer, and Bernard Anzarouth, Chief Investment Officer will be available during the March 10, 2026 conference call to answer questions regarding the Company’s results. To access the call, please dial 1-877-879-1183 (North America toll free) or 1-412-902-6703 (International) and using conference ID 8822692.  A conference operator will create a queue...

VANCOUVER, British Columbia, Feb. 17, 2026 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) President and Chief Executive Officer Jonathan Price, will be presenting at the BMO Global Metals, Mining & Critical Minerals conference on Monday, February 23, 2026, at 1:30 p.m. Eastern/10:30 a.m. Pacific time. The investor presentation will include information on company strategy, financial performance, and outlook for the company’s business units. The presentation will be webcast through the following link at: https://app.webinar.net/PNYBpm6JGbj. Alternatively, the webcast with supporting slides will be available on Teck’s website at: www.teck.com. About TeckTeck is a leading Canadian resource company focused on responsibly providing metals essential to economic development and the energy transition....

MELBOURNE, Australia and INDIANAPOLIS, Feb. 18, 2026 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that it has submitted a marketing authorization application (MAA) in Europe for TLX101-Px (O-(2-[18F]fluoroethyl)-L-tyrosine, 18F-FET), its glioma (brain cancer) imaging candidate. Telix has been preparing the European and U.S. regulatory packages for TLX101-Px concurrently, bringing forward the European submission to meet an agreed filing date while aligning with aspects of the U.S. Food and Drug Administration (FDA) package to support the additional application. The submission covers major European markets1. Telix is seeking to expand patient access to advanced brain imaging through a broad clinical label, reflective of current clinical practice guidelines2. Submission of the U.S....

NEW YORK and TORONTO, Feb. 17, 2026 (GLOBE NEWSWIRE) — iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCID: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, announces continued progress across its retail expansion, brand development and capital structure initiatives. In Florida, the Company plans to open its 26th GrowHealthy dispensary in Tequesta, FL, further expanding its footprint in a core market. GrowHealthy’s Tequesta dispensary is currently scheduled to open on or about March 27, 2026, subject to receipt of necessary regulatory approvals, and is intended to improve patient access in Palm Beach County, while supporting the Company’s continued growth across the state. “The Tequesta store is designed to better serve patients in northern Palm Beach...